SCCE
Sachem Capital Corp. 6.00% Note
REIT - Industrial
Market Cap$1.14B
5Y Perf.-2.8%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
SCCE vs LOAN
Revenue, margins, valuation, and 5-year total return — side by side.
LOAN
Manhattan Bridge Capital, Inc.
REIT - Mortgage
Market Cap$49M
5Y Perf.-33.1%
SCCE vs LOAN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | SCCE | LOAN |
|---|---|---|
| Industry | REIT - Industrial | REIT - Mortgage |
| Market Cap | $1.14B | $49M |
| Revenue (TTM) | $-13M | $8M |
| Net Income (TTM) | $4M | $5M |
| Gross Margin | — | 99.9% |
| Operating Margin | — | 58.1% |
| Forward P/E | 600.0x | 8.7x |
| Total Debt | $0.00 | $23M |
| Cash & Equiv. | $11M | $178K |
SCCE vs LOAN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
SCCE
LOAN
| Stock | Mar 22 | May 26 | Return |
|---|---|---|---|
| Sachem Capital Corp… (SCCE) | 100 | 97.2 | -2.8% |
| Manhattan Bridge Ca… (LOAN) | 100 | 66.9 | -33.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SCCE vs LOAN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: LOAN leads in 4 of 6 categories, making it the strongest pick for valuation and capital efficiency and capital preservation and lower volatility. Sachem Capital Corp. 6.00% Note is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
SCCE
Sachem Capital Corp. 6.00% Note
The Real Estate Income Play
SCCE is the clearest fit if your priority is growth exposure.
- Rev growth 100.0%, EPS growth 104.3%
- 100.0% FFO/revenue growth vs LOAN's 32.7%
- +35.3% vs LOAN's -8.1%
Best for: growth exposure
LOAN
Manhattan Bridge Capital, Inc.
The Real Estate Income Play
LOAN carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 0 yrs, beta 0.12, yield 10.8%
- 102.3% 10Y total return vs SCCE's 29.1%
- Lower volatility, beta 0.12, Low D/E 52.1%, current ratio 31.09x
Best for: income & stability and long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | SCCE | 100.0% FFO/revenue growth vs LOAN's 32.7% |
| Value | LOAN | Lower P/E (8.7x vs 600.0x) |
| Stability / Safety | LOAN | Beta 0.12 vs SCCE's 0.69 |
| Dividends | LOAN | 10.8% yield, vs SCCE's 0.8% |
| Momentum (1Y) | SCCE | +35.3% vs LOAN's -8.1% |
| Efficiency (ROA) | LOAN | 8.1% ROA vs SCCE's 0.8% |
SCCE vs LOAN — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLLOANLAGGINGSCCE
SCCESachem Capital Corp. …
1leads
LOANManhattan Bridge Capi…
4leads
6 Total Categories
CATEGORYLEADERvs SCCEMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
LOAN2/2
Valuation MetricsMultiples, price ratios, and targets
LOAN3/3
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
LOAN3/5
Total Returns1Y, 3Y, 5Y total returns with dividends
SCCE5/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
LOAN1/1
Income & Cash Flow (Last 12 Months)
LOAN leads this category, winning 2 of 2 comparable metrics.
Income & Cash Flow (Last 12 Months)
LOAN and SCCE operate at a comparable scale, with $8M and -$13M in trailing revenue. On growth, LOAN holds the edge at +14.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | SCCESachem Capital Co… | LOANManhattan Bridge … |
|---|---|---|
| RevenueTrailing 12 months | -$13M | $8M |
| EBITDAEarnings before interest/tax | $551,999 | $4M |
| Net IncomeAfter-tax profit | $4M | $5M |
| Free Cash FlowCash after capex | $3M | $5M |
| Gross MarginGross profit ÷ Revenue | — | +99.9% |
| Operating MarginEBIT ÷ Revenue | — | +58.1% |
| Net MarginNet income ÷ Revenue | — | +70.0% |
| FCF MarginFCF ÷ Revenue | — | +62.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | -2.6% | +14.6% |
| EPS Growth (YoY)Latest quarter vs prior year | -81.9% | -8.3% |
LOAN leads this category, winning 2 of 2 comparable metrics.
Valuation Metrics
LOAN leads this category, winning 3 of 3 comparable metrics.
Valuation Metrics
At 8.7x trailing earnings, LOAN trades at a 99% valuation discount to SCCE's 600.0x P/E.
| Metric | SCCESachem Capital Co… | LOANManhattan Bridge … |
|---|---|---|
| Market CapShares × price | $1.1B | $49M |
| Enterprise ValueMkt cap + debt − cash | $1.1B | $71M |
| Trailing P/EPrice ÷ TTM EPS | 600.00x | 8.67x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 8.97x |
| Price / SalesMarket cap ÷ Revenue | — | 5.02x |
| Price / BookPrice ÷ Book value/share | 6.43x | 1.12x |
| Price / FCFMarket cap ÷ FCF | 457.78x | 9.87x |
LOAN leads this category, winning 3 of 3 comparable metrics.
Profitability & Efficiency
LOAN leads this category, winning 3 of 5 comparable metrics.
Profitability & Efficiency
LOAN delivers a 12.2% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $2 for SCCE. On the Piotroski fundamental quality scale (0–9), LOAN scores 7/9 vs SCCE's 5/9, reflecting strong financial health.
| Metric | SCCESachem Capital Co… | LOANManhattan Bridge … |
|---|---|---|
| ROE (TTM)Return on equity | +2.3% | +12.2% |
| ROA (TTM)Return on assets | +0.8% | +8.1% |
| ROICReturn on invested capital | — | +8.5% |
| ROCEReturn on capital employed | — | +11.3% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 |
| Debt / EquityFinancial leverage | — | 0.52x |
| Net DebtTotal debt minus cash | -$11M | $22M |
| Cash & Equiv.Liquid assets | $11M | $178,012 |
| Total DebtShort + long-term debt | $0 | $23M |
| Interest CoverageEBIT ÷ Interest expense | — | 3.38x |
LOAN leads this category, winning 3 of 5 comparable metrics.
Total Returns (Dividends Reinvested)
SCCE leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SCCE five years ago would be worth $12,914 today (with dividends reinvested), compared to $10,353 for LOAN. Over the past 12 months, SCCE leads with a +35.3% total return vs LOAN's -8.1%. The 3-year compound annual growth rate (CAGR) favors SCCE at 13.7% vs LOAN's 5.3% — a key indicator of consistent wealth creation.
| Metric | SCCESachem Capital Co… | LOANManhattan Bridge … |
|---|---|---|
| YTD ReturnYear-to-date | +5.0% | -5.8% |
| 1-Year ReturnPast 12 months | +35.3% | -8.1% |
| 3-Year ReturnCumulative with dividends | +47.2% | +16.8% |
| 5-Year ReturnCumulative with dividends | +29.1% | +3.5% |
| 10-Year ReturnCumulative with dividends | +29.1% | +102.3% |
| CAGR (3Y)Annualised 3-year return | +13.7% | +5.3% |
SCCE leads this category, winning 5 of 6 comparable metrics.
Risk & Volatility
Evenly matched — SCCE and LOAN each lead in 1 of 2 comparable metrics.
Risk & Volatility
LOAN is the less volatile stock with a 0.12 beta — it tends to amplify market swings less than SCCE's 0.69 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SCCE currently trades 97.6% from its 52-week high vs LOAN's 72.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | SCCESachem Capital Co… | LOANManhattan Bridge … |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.69x | 0.12x |
| 52-Week HighHighest price in past year | $24.59 | $5.85 |
| 52-Week LowLowest price in past year | $11.14 | $4.13 |
| % of 52W HighCurrent price vs 52-week peak | +97.6% | +72.6% |
| RSI (14)Momentum oscillator 0–100 | 65.6 | 39.5 |
| Avg Volume (50D)Average daily shares traded | 5K | 27K |
Evenly matched — SCCE and LOAN each lead in 1 of 2 comparable metrics.
Analyst Outlook
LOAN leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
For income investors, LOAN offers the higher dividend yield at 10.77% vs SCCE's 0.84%.
| Metric | SCCESachem Capital Co… | LOANManhattan Bridge … |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — |
| Price TargetConsensus 12-month target | — | — |
| # AnalystsCovering analysts | — | — |
| Dividend YieldAnnual dividend ÷ price | +0.8% | +10.8% |
| Dividend StreakConsecutive years of raises | 0 | 0 |
| Dividend / ShareAnnual DPS | $0.20 | $0.46 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.0% |
LOAN leads this category, winning 1 of 1 comparable metric.
Key Takeaway
LOAN leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). SCCE leads in 1 (Total Returns). 1 tied.
Best OverallManhattan Bridge Capital, I… (LOAN)Leads 4 of 6 categories
Loading custom metrics...
SCCE vs LOAN: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is SCCE or LOAN a better buy right now?
For growth investors, Sachem Capital Corp.
6. 00% Note (SCCE) is the stronger pick with 100. 0% revenue growth year-over-year, versus 32. 7% for Manhattan Bridge Capital, Inc. (LOAN). Manhattan Bridge Capital, Inc. (LOAN) offers the better valuation at 8. 7x trailing P/E, making it the more compelling value choice. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SCCE or LOAN?
On trailing P/E, Manhattan Bridge Capital, Inc.
(LOAN) is the cheapest at 8. 7x versus Sachem Capital Corp. 6. 00% Note at 600. 0x.
03Which is the better long-term investment — SCCE or LOAN?
Over the past 5 years, Sachem Capital Corp.
6. 00% Note (SCCE) delivered a total return of +29. 1%, compared to +3. 5% for Manhattan Bridge Capital, Inc. (LOAN). Over 10 years, the gap is even starker: LOAN returned +102. 3% versus SCCE's +29. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SCCE or LOAN?
By beta (market sensitivity over 5 years), Manhattan Bridge Capital, Inc.
(LOAN) is the lower-risk stock at 0. 12β versus Sachem Capital Corp. 6. 00% Note's 0. 69β — meaning SCCE is approximately 480% more volatile than LOAN relative to the S&P 500.
05Which is growing faster — SCCE or LOAN?
By revenue growth (latest reported year), Sachem Capital Corp.
6. 00% Note (SCCE) is pulling ahead at 100. 0% versus 32. 7% for Manhattan Bridge Capital, Inc. (LOAN). On earnings-per-share growth, the picture is similar: Sachem Capital Corp. 6. 00% Note grew EPS 104. 3% year-over-year, compared to 2. 1% for Manhattan Bridge Capital, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SCCE or LOAN?
Manhattan Bridge Capital, Inc.
(LOAN) is the more profitable company, earning 57. 7% net margin versus 0. 0% for Sachem Capital Corp. 6. 00% Note — meaning it keeps 57. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LOAN leads at 81. 6% versus 0. 0% for SCCE. At the gross margin level — before operating expenses — LOAN leads at 76. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Which pays a better dividend — SCCE or LOAN?
All stocks in this comparison pay dividends.
Manhattan Bridge Capital, Inc. (LOAN) offers the highest yield at 10. 8%, versus 0. 8% for Sachem Capital Corp. 6. 00% Note (SCCE).
08Is SCCE or LOAN better for a retirement portfolio?
For long-horizon retirement investors, Manhattan Bridge Capital, Inc.
(LOAN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 12), 10. 8% yield, +102. 3% 10Y return). Both have compounded well over 10 years (LOAN: +102. 3%, SCCE: +29. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between SCCE and LOAN?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(SCCE: -256.5% · LOAN: 14.6%)P/E Ratio<
x
(SCCE: 600.0x · LOAN: 8.7x)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.